Want to be on the show? Email me! matt.custodero@gmail.com
Sources:
SNT:
https://www.psychiatryadvisor.com/home/topics/mood-disorders/depressive-disorder/fda-clears-saint-neuromodulation-system-for-major-depressive-disorder/
https://www.medicaldevice-network.com/news/magnus-saint-neuromodulation-system-fda/
https://ajp.psychiatryonline.org/doi/abs/10.1176/appi.ajp.2021.20101429
TACS:
https://www.lifespan.io/news/neuromodulation-improves-memory-in-older-adults/
https://www.nature.com/articles/s41593-022-01132-3#Tab1
Business:
https://www.globenewswire.com/en/news-release/2022/09/05/2509762/0/en/Neuromodulation-Devices-Market-to-Hit-14-16-Billion-by-2030-Growing-at-a-CAGR-of-10-29.html
